Related references
Note: Only part of the references are listed.Targeting glycogen synthase kinase 3 for therapeutic benefit in lymphoma
Xiaosheng Wu et al.
BLOOD (2019)
9-ING-41, a small-molecule glycogen synthase kinase-3 inhibitor, is active in neuroblastoma
Andrey V. Ugolkov et al.
ANTI-CANCER DRUGS (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Glycogen synthase kinase-3β ablation limits pancreatitis-induced acinar-to-ductal metaplasia
Li Ding et al.
JOURNAL OF PATHOLOGY (2017)
Combination Treatment with the GSK-3 Inhibitor 9-ING-41 and CCNU Cures Orthotopic Chemoresistant Glioblastoma in Patient-Derived Xenograft Models
Andrey Ugolkov et al.
TRANSLATIONAL ONCOLOGY (2017)
GSK-3β inhibitor, 9-ING-41, reduces cell viability and halts proliferation of B-cell lymphoma cell lines as a single agent and in combination with novel agents
Reem Karmali et al.
ONCOTARGET (2017)
Lithium enhances the antitumour effect of temozolomide against TP53 wild-type glioblastoma cells via NFAT1/FasL signalling
Sheng Han et al.
BRITISH JOURNAL OF CANCER (2017)
Molecular Pathways: Revisiting Glycogen Synthase Kinase-3β as a Target for the Treatment of Cancer
Amy Walz et al.
CLINICAL CANCER RESEARCH (2017)
Gsk-3β Controls Autophagy by Modulating LKB1-AMPK Pathway in Prostate Cancer Cells
Aijing Sun et al.
PROSTATE (2016)
GSK-3 inhibition overcomes chemoresistance in human breast cancer
Andrey Ugolkov et al.
CANCER LETTERS (2016)
Molecular biology and targeted therapies for urothelial carcinoma
Emmanuel Seront et al.
CANCER TREATMENT REVIEWS (2015)
Autophagy in malignant transformation and cancer progression
Lorenzo Galluzzi et al.
EMBO JOURNAL (2015)
Glycogen Synthase Kinase-3 (GSK3) Inhibition Induces Prosurvival Autophagic Signals in Human Pancreatic Cancer Cells
Benoit Marchand et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Combined regulation of mTORC1 and lysosomal acidification by GSK-3 suppresses autophagy and contributes to cancer cell growth
I. Azoulay-Alfaguter et al.
ONCOGENE (2015)
Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti-PD-1 Therapy
Janis M. Taube et al.
CLINICAL CANCER RESEARCH (2014)
Inhibition of GSK3B Bypass Drug Resistance of p53-Null Colon Carcinomas by Enabling Necroptosis in Response to Chemotherapy
Emanuela Grassilli et al.
CLINICAL CANCER RESEARCH (2013)
Targeting autophagy potentiates chemotherapy-induced apoptosis and proliferation inhibition in hepatocarcinoma cells
Xian-ling Guo et al.
CANCER LETTERS (2012)
Inhibition of autophagy potentiates the antitumor effect of the multikinase inhibitor sorafenib in hepatocellular carcinoma
Satoshi Shimizu et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
GSK3: a key target for the development of novel treatments for type 2 diabetes mellitus and Alzheimer disease
Chong Gao et al.
REVIEWS IN THE NEUROSCIENCES (2012)
Glycogen synthase kinase 3β inhibitors induce apoptosis in ovarian cancer cells and inhibit in-vivo tumor growth
Tyvette S. Hilliard et al.
ANTI-CANCER DRUGS (2011)
LiCl induces TNF-α and FasL production, thereby stimulating apoptosis in cancer cells
Larissa Kaufmann et al.
CELL COMMUNICATION AND SIGNALING (2011)
Glycogen Synthase Kinase-3β: A Prognostic Marker and a Potential Therapeutic Target in Human Bladder Cancer
Sei Naito et al.
CLINICAL CANCER RESEARCH (2010)
From a Natural Product Lead to the Identification of Potent and Selective Benzofuran-3-yl-(indol-3-yl)maleimides as Glycogen Synthase Kinase 3β Inhibitors That Suppress Proliferation and Survival of Pancreatic Cancer Cells
Irina N. Gaisina et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Growth control of multiple myeloma cells through inhibition of glycogen synthase kinase-3
Ying Zhou et al.
LEUKEMIA & LYMPHOMA (2008)
Inhibition of glycogen synthase kinase-3 activity leads to epigenetic silencing of nuclear factor κB target genes and induction of apoptosis in chronic lymphocytic leukemia B cells
Andrei V. Ougolkov et al.
BLOOD (2007)
Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma
Ravi K. Amaravadi et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Pharmacologic modulation of glycogen synthase kinase-3β promotes p53-dependent apoptosis through a direct bax-mediated mitochondrial pathway in colorectal cancer cells
J Tan et al.
CANCER RESEARCH (2005)
Glycogen synthase kinase-3β participates in nuclear factor κB-mediated gene transcription and cell survival in pancreatic cancer cells
AV Ougolkov et al.
CANCER RESEARCH (2005)
Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation
KP Hoeflich et al.
NATURE (2000)
Share Paper
